Characterization of the anticonvulsant properties of F-721.

No abstract is available for this paper.

• Publication year

  1993

• Venue

  Epilepsy Research

• Publication date

  1993-05-01

• Fields of study

  Medicine, Chemistry

• Identifiers
  DOI 10.1016/0920-1211(93)90007-TPMID 8391982
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• A Neuropharmacological Evaluation of Felbamate as a Novel Anticonvulsant

  1992cited by this paper
• A History of Stroke

  1990cited by this paper
• [3H]CGS 21680, a selective A2 adenosine receptor agonist directly labels A2 receptors in rat brain.

  1989cited by this paper
• Binding of [3H]3-(2-carboxypiperazin-4-yl)propyl-1-phosphonic acid to rat brain membranes: a selective, high-affinity ligand for N-methyl-D-aspartate receptors.

  1987cited by this paper
• 8-Cyclopentyl-1,3-dipropylxanthine (DPCPX) — a selective high affinity antagonist radioligand for A1 adenosine receptors

  1987cited by this paper
• The novel anticonvulsant MK-801: a potent and specific ligand of the brain phencyclidine/sigma-receptor.

  1987cited by this paper
• The novel anticonvulsant MK-801: a potent and specific ligand of the brain phencyclidine/gd-receptor

  1987cited by this paper
• Carbamazepine and 10,11-epoxycarbamazepine produce use- and voltage-dependent limitation of rapidly firing action potentials of mouse central neurons in cell culture.

  1986cited by this paper
• Multiple actions of phenytoin on mouse spinal cord neurons in cell culture.

  1983cited by this paper
• Inhibition of adenosine uptake into rat brain synaptosomes by the benzodiazepines.

  1981cited by this paper
• Anticonvulsant drugs and their antagonism of kindled amygdaloid seizures in rats.

  1980cited by this paper
• Antiepileptic Drug Development: II. Anticonvulsant Drug Screening

  1978cited by this paper
• Mouse spinal cord in cell culture. I. Morphology and intrinsic neuronal electrophysiologic properties.

  1977cited by this paper
• Specific benzodiazepine receptors in rat brain characterized by high-affinity (3H)diazepam binding.

  1977cited by this paper
• Properties of gamma-aminobutyric acid (GABA) receptor binding in rat brain synaptic membrane fractions.

  1975cited by this paper
• Properties of γ-aminobutyric acid (GABA) receptor binding in rat brain synaptic membrane fractions

  1975cited by this paper
• Gamma-aminobutyric acid binding to receptor sites in the rat central nervous system.

  1974cited by this paper
• Modification of seizure activity by electrical stimulation. II. Motor seizure.

  1972cited by this paper
• A note on a simple apparatus for detecting neurological deficit in rats and mice.

  1957cited by this paper
• Design and use of a new electroshock seizure apparatus, and analysis of factors altering seizure threshold and pattern.

  1952cited by this paper
• Design and use of a new electroshock seizure apparatus, and analysis of factors altering seizure threshold and pattern.

  1952cited by this paper
• Protein measurement with the Folin phenol reagent.

  1951cited by this paper
• Timed Intravenous Infusion of Metrazol and Strychnine for Testing Anticonvulsant Drugs.*

  1949cited by this paper
• A simplified method of evaluating dose-effect experiments.

  1948cited by this paper

• Animal Models of Drug-Resistant Epilepsy as Tools for Deciphering the Cellular and Molecular Mechanisms of Pharmacoresistance and Discovering More Effective Treatments

  2023cites this paper
• Can pentylenetetrazole and maximal electroshock rodent seizure models quantitatively predict antiepileptic efficacy in humans?

  2015cites this paper
• SYNTHESIS OF SOME NEW OXINDOLE DERIVATIVES AS POTENTIAL ANTIPSYCHOTIC AND ANTICONVULSANT AGENTS

  2011cites this paper
• The anticonvulsant profile of rufinamide (CGP 33101) in rodent seizure models

  2008cites this paper
• Nefopam blocks voltage-sensitive sodium channels and modulates glutamatergic transmission in rodents.

  2004cites this paper
• Animal Models of Epilepsy and Epileptic Seizures

  1999cites this paper
• Corneal kindling in mice: behavioral and pharmacological differences to conventional kindling.

  1999cites this paper
• Anticonvulsant activities of 4‐(4′‐fluorophenoxy) benzaldehyde semicarbazone

  1999cites this paper
• Validation of corneally kindled mice: a sensitive screening model for partial epilepsy in man.

  1998cites this paper
• AWD 140-190: a new anticonvulsant with a very good margin of safety.

  1997cites this paper
• Characterization of the Anticonvulsant Properties of Ganaxolone (CCD 1042; 3α-Hydroxy-3β-methyl-5α-pregnan-20-one), a Selective, High-Affinity, Steroid Modulator of the γ-Aminobutyric AcidA Receptor

  1997cites this paper
• Preclinical characterization of MDL 27,192 as a potential broad spectrum anticonvulsant agent with neuroprotective properties.

  1997cites this paper
• Characterization of the anticonvulsant properties of ganaxolone (CCD 1042; 3alpha-hydroxy-3beta-methyl-5alpha-pregnan-20-one), a selective, high-affinity, steroid modulator of the gamma-aminobutyric acid(A) receptor.

  1997cites this paper
• D-23129: a new anticonvulsant with a broad spectrum activity in animal models of epileptic seizures.

  1996cites this paper
• Problems in the Assessment of Potential Antiepileptic Drugs

  1994cites this paper
• Strategies in antiepileptic drug development: is rational drug design superior to random screening and structural variation?

  1994cites this paper
• Developments in antiepileptic drug therapy.

  1994cites this paper